Literature DB >> 8491521

Shigellemia in AIDS patients: case report and review of the literature.

J Huebner1, W Czerwenka, E Gruner, A von Graevenitz.   

Abstract

Shigella bacteremia in adult patients is rare and is usually associated with immunosuppressive diseases. To date, 12 HIV-positive patients with Shigella bacteremia have been reported in the medical literature. We report a case of Shigella dysenteriae bacteremia in a 39-year-old HIV-positive patient. Although the patient presented with bloody and watery diarrhea, stool cultures failed to grow enteric pathogens. The patient responded well to appropriate antibiotic therapy.

Entities:  

Mesh：

Year:  1993        PMID： 8491521     DOI： 10.1007/BF01710748

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  24 in total

1.  Shigella bacteremia.

Authors:  M P Johnson; B S Bender
Journal:  Arch Intern Med       Date:  1988-03

2.  Shigellemia without shigella diarrhea. Report of a case.

Authors:  C D Graber; D Browning; J S Davis
Journal:  Am J Clin Pathol       Date:  1966-08       Impact factor: 2.493

Review 3.  Pathogenesis of Shigella infections.

Authors:  T L Hale; S B Formal
Journal:  Pathol Immunopathol Res       Date:  1987

Review 4.  Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens.

Authors:  J J Farmer; B R Davis; F W Hickman-Brenner; A McWhorter; G P Huntley-Carter; M A Asbury; C Riddle; H G Wathen-Grady; C Elias; G R Fanning
Journal:  J Clin Microbiol       Date:  1985-01       Impact factor: 5.948

5.  Four cases of Shigella septicemia in Israel.

Authors:  M Alkan; E Salzstein; A Simu
Journal:  Eur J Clin Microbiol       Date:  1985-08       Impact factor: 3.267

6.  Shigella sonnei bacteremia in an elderly diabetic patient.

Authors:  F Dronda; F Parras; J L Martínez; F Baquero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

7.  Bacteremia and fungemia in patients with the acquired immunodeficiency syndrome.

Authors:  E Whimbey; J W Gold; B Polsky; J Dryjanski; C Hawkins; A Blevins; P Brannon; T E Kiehn; A E Brown; D Armstrong
Journal:  Ann Intern Med       Date:  1986-04       Impact factor: 25.391

8.  Antigenic relationships between the enteroinvasive Escherichia coli O antigens O28ac, O112ac, O124, O136, O143, O144, O152, and O164 and Shigella O antigens.

Authors:  T Cheasty; B Rowe
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

9.  Shigella sepsis.

Authors:  B Duncan; V A Fulginiti; O F Sieber; K J Ryan
Journal:  Am J Dis Child       Date:  1981-02

10.  Shigella septicaemia following renal transplantation.

Authors:  M Severn; J Michael
Journal:  Postgrad Med J       Date:  1980-12       Impact factor: 2.401
View more
  5 in total

1.  Resignment: Infection is grateful to Prof. Alexander von Graevenitz.

Authors:  Johannes R Bogner
Journal:  Infection       Date:  2018-12       Impact factor: 3.553

Review 2.  Antibiotic therapy for Shigella dysentery.

Authors:  Prince Rh Christopher; Kirubah V David; Sushil M John; Venkatesan Sankarapandian
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04

3.  Symptomatic Shigella sonnei urinary tract infection.

Authors:  C J Papasian; S Enna-Kifer; B Garrison
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

4.  Shigella bacteremia in a patient with visceral leishmaniasis.

Authors:  Mengistu Endris; Rezika Mohammed; Yegnasew Takele; Desalegn Woldeyohannes; Moges Tiruneh; Ermias Diro
Journal:  Case Rep Crit Care       Date:  2013-08-19

5.  Changing epidemiology of shigellosis in Taiwan, 2010-2019: an emerging threat to HIV-infected patients and men who have sex with men.

Authors:  Chin-Shiang Tsai; Kuan-Yin Lin; Bo-Huang Liou; Chien-Shun Chiou; Yi-Chun Lin; Yuan-Ti Lee; Chia-Jui Yang; Hung-Jen Tang; Ying-Shu Liao; Chun-Eng Liu; Chen-Hsiang Lee; Po-Liang Lu; Sung-Hsi Huang; Chien-Ching Hung; Wen-Chien Ko
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.